Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Gross Profit: 2020-2025

Historic Gross Profit for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $2.2 million.

  • Caribou Biosciences' Gross Profit rose 8.60% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 19.00%. This contributed to the annual value of $10.0 million for FY2024, which is 71.01% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Gross Profit is $2.2 million, which was down 17.59% from $2.7 million recorded in Q2 2025.
  • Caribou Biosciences' Gross Profit's 5-year high stood at $23.7 million during Q3 2023, with a 5-year trough of $1.5 million in Q2 2021.
  • For the 3-year period, Caribou Biosciences' Gross Profit averaged around $4.7 million, with its median value being $2.7 million (2025).
  • As far as peak fluctuations go, Caribou Biosciences' Gross Profit spiked by 616.38% in 2023, and later crashed by 91.45% in 2024.
  • Caribou Biosciences' Gross Profit (Quarterly) stood at $2.6 million in 2021, then skyrocketed by 44.28% to $3.7 million in 2022, then dropped by 3.63% to $3.6 million in 2023, then plummeted by 41.62% to $2.1 million in 2024, then climbed by 8.60% to $2.2 million in 2025.
  • Its Gross Profit stands at $2.2 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.4 million for Q1 2025.